# Pharmacogenomics of Antiplatelet Response - I

> **NCT01815008** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 19 (actual)

## Conditions studied

- Platelet Aggregation
- Platelet Transcriptome
- Coronary Artery Disease

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT01815008
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01815008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01815008, "Pharmacogenomics of Antiplatelet Response - I". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01815008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*